Parabilis Medicines
PBLS----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Parabilis Medicines(PBLS) the EBIT is -47.45 M (-21.1%);the EPS is -22.47 (-45.01%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.05B21.10%
----
----
EPS
-22.467445.01%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf